Access To The WHO Global TB Database: Annex
Access To The WHO Global TB Database: Annex
Access To The WHO Global TB Database: Annex
1
Access to
the WHO global
TB database
::
A.1 Database contents
The 2016 global TB report is based on data collected annually from countries and territories, including 194 Member States.
These data are stored in the global TB database.
In 2016, data were collected on the following topics: TB case notifications and treatment outcomes, including break-
downs by TB case type, age, sex , HIV status and drug resistance; laboratory diagnostic services; monitoring and eval-
uation, including surveillance and surveys specifically related to drug-resistant TB; TB preventive therapy; TB infection
control; engagement of all public and private care providers in TB control; community engagement; the budgets of national
TB control programmes (NTPs); utilization of general health services (hospitalization and outpatient visits) during treat-
ment; and NTP expenditures. A shortened version of the online questionnaire was used for high-income countries (that
is, countries with a gross national income per capita of US$12476 in 2015, as defined by the World Bank)1 and/or low-
incidence countries (defined as countries with an incidence rate of <20 cases per 100000 population or <10 cases in total).
Countries reported data using a dedicated website (https://extranet.who.int/tme), which was opened for reporting
in early April 2016. Countries in the European Union submitted notification and treatment outcomes data to the TESSy
system managed by the European Centre for Disease Prevention and Control (ECDC). Data from TESSy were uploaded into
the global TB database.
Additional data about the provision of isoniazid preventive therapy (IPT) to people living with HIV and antiretroviral
therapy (ART) for HIV-positive TB patients were collected by the Joint United Nations Programme on HIV/AIDS (UNAIDS)
and the HIV department in WHO. These data were jointly validated by UNAIDS and the WHOs Global TB Programme and
HIV department, and uploaded into the global TB database.
Following review and follow-up with countries, the data used for the main part of this report were those data available on
15 August 2016. The number of countries and territories that had reported data by 15 August 2016 is shown in Table A1.1.
:: TABLE A1.1
Reporting of data in the 2016 round of global TB data collection
COUNTRIES AND TERRITORIES WHO MEMBER STATES
WHO REGION OR SET OF COUNTRIES NUMBER NUMBER THAT REPORTED DATA NUMBER NUMBER THAT REPORTED DATA
African Region 47 46 47 46
Region of the Americas 46 41 35 33
Eastern Mediterranean Region 22 20 21 19
European Region 54 48 53 47
South-East Asia Region 11 11 11 11
Western Pacific Region 36 36 27 27
Global 216 202 194 183
a
Countries that did not report by the deadline were mostly low-incidence countries in Western Europe.
1
http://data.worldbank.org/about/country-classifications
:: FIG. A1.1
Interactive page to view MDR-TB indicators by region or country and year
50000
2007
40000
2008
Number of cases
30000 2009
year
2010
20000
2011
10000
2012
0
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 0 20 40 60 80 100
year % of cohort
Outcomes for MDR-TB treatment are reported two years after the end of the year of enrolment. Patients may not necessarily have been treated using internationally-recommended regimens or norms.
% TB cases with 1st line DST exceeding 100% are shown as 100%; this may happen if TB notification is incomplete especially in systems where reporting of TB and DST are not linked.